Cipla Points To Large GLP-1 India Opportunity Amid Speculation On Lilly Deal

As Executive Vice-Chair Samina Hamied Moves To Non-Exec Role

Strong Q3 FY24 run for Cipla, GLP-1 opportunities loom • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business